• Info
  • Insider Ownership

Insider Trading & Ownership of Kristin Abate

Location
Newton, MA
Summary
The estimated net worth of Kristin Abate is at least $159,032 dollars as of 29 Jan 2026. Kristin Abate is the Chief Accounting Officer of Karyopharm Therapeutics Inc. and owns shares of Karyopharm Therapeutics Inc. (KPTI) stock worth about $159K.
Signature
/s/ Nancy Smith as Attorney-in-Fact for Kristin Abate
All Insider Reports
All Insider Reports

Notify me when Kristin Abate files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Kristin Abate

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
KPTI Karyopharm Therapeutics Inc. Chief Accounting Officer $159,032 -$5,391 -3.3% 27 Jan 2026

Insider Transactions Reported by Kristin Abate:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.